Healthcare & Life Sciences
Adaptive Phage Therapeutics
United Stateswww.aphage.com/
Adaptive Phage Therapeutics is a series b startup based in United States. 2 investors tracked.
Activeseries-b
series-b
Stage
2010
Founded
1
Investors
About Adaptive Phage Therapeutics
Adaptive Phage Therapeutics is a startup founded in 2010 based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing a phage-based therapeutic approach for the treatment of multi-drug resistant bacterial infections.
Explore Adaptive Phage Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.